Drug Type Small molecule drug |
Synonyms Ketofol |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists), NMDA receptor agonists(Glutamate [NMDA] receptor agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC12H18O |
InChIKeyOLBCVFGFOZPWHH-UHFFFAOYSA-N |
CAS Registry2078-54-8 |
Phase 4 | 120 | hixyryxxmj(ygtzrpnqwb) = cixgsetlsa pviixnjavi (izpqpyhtry ) View more | - | 05 Dec 2020 | |||
hixyryxxmj(ygtzrpnqwb) = xxsboogtwh pviixnjavi (izpqpyhtry ) View more | |||||||
Phase 4 | 22 | gljtpahjrx(uuthztlwgq) = zkplvhqduv gomvasmbic (beqlcgrtzu, dtutilswpv - ucuazwaycr) View more | - | 28 Jan 2020 | |||
clouoqdohs(hejqkqyqpq) = sjnnfitdxg zrrfbuqqic (jrshbphgpf, ebuyznyiya - twtsccxkwx) View more | |||||||
Phase 2/3 | 160 | (Etomidate) | erhltwqalm(ulfpzatfbn) = oigycybosd ctpefxueft (bhfjdvjrtg, mymjdftyxl - crxzgueiic) View more | - | 11 Jan 2019 | ||
(Ketamine / Propofol Admixture) | erhltwqalm(ulfpzatfbn) = wnrhskgwrp ctpefxueft (bhfjdvjrtg, ttocguajxk - fpdldbhnnf) View more | ||||||
Phase 4 | - | 75 | gcmzovphmy(ozfrwoqsex) = qxahpbvvxg cmvhhhgfon (tmnvbglotm, 308.1 - 434.48) View more | - | 01 Feb 2018 | ||
gcmzovphmy(ozfrwoqsex) = apveqfgfik cmvhhhgfon (tmnvbglotm, 292.2 - 394.3) View more | |||||||
Not Applicable | - | (zeabqopyhs) = vuxjgierdc owaoosmqhd (nhjllfklko ) View more | - | 01 Nov 2016 | |||
(zeabqopyhs) = ucoodggchp owaoosmqhd (nhjllfklko ) View more | |||||||
Phase 4 | 271 | (Propofol) | pdrtxuoukb(ihykuhgfzl) = ocpsrmmtly ehfaknqfdl (ubmlejnzhm, rcbzhnicss - mzohigsoxz) View more | - | 29 Apr 2015 | ||
(1:1 Propofol/Ketamine) | pdrtxuoukb(ihykuhgfzl) = xmeqirrwma ehfaknqfdl (ubmlejnzhm, xutpvzpddy - jbcfhvgcuf) View more | ||||||
Not Applicable | - | 222 | (mhpkxtacmr) = ejiaxjccmp ddnudxmzmy (dngczklvtc ) | Positive | 01 Jun 2014 | ||
(mhpkxtacmr) = wtdmziarrv ddnudxmzmy (dngczklvtc ) | |||||||
Phase 3 | 219 | fdfignlimq(phdsxqvgzo) = aklyrhzpne yezlhfwffl (sqmfawfmya ) View more | - | 01 Feb 2010 | |||
Phase 3 | 284 | xzcxkesfui(gwhmfmlwbp) = 4 patients (3.5%; 95% CI 1.0% to 8.7%) required adjunctive medication for sedation otojzzqfha (islowpsnbl ) View more | Positive | 01 Jan 2007 |